Isosceles Pharmaceuticals
PrivateLast Round
Seed
May 1, 2023
Total Funding Raised
$5.02M
Company Overview
Isosceles Pharmaceuticals operates in Healthcare & Life Sciences and is based in Wilmington, North Carolina. Its latest recorded funding round was a Seed round in May 2023.
Isosceles Pharmaceuticals is a biotechnology company that develops non-opioid, non-NSAID analgesic delivery systems and synthetic small-molecule immunotherapy adjuvants for pain management and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isosceles Pharmaceuticals Comparables
Compare Isosceles Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoGenesis | 79% | |
| Teon Therapeutics | 76% | |
| Lurex Bio, Inc. | 59% |
For institutional investors. Book with your work email.
Isosceles Pharmaceuticals Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Isosceles Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Carolina Biotechnology Center | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2025
Monthly visitors grew 33% MoM, from 273 to 364.
- May 4, 2025
Monthly visitors grew 368% MoM, reaching 795.
For institutional investors. Book with your work email.
Isosceles Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Isosceles Pharmaceuticals's valuation, stock price, and market status.
Is Isosceles Pharmaceuticals a public or private company?
Isosceles Pharmaceuticals is a private company.
What is the current stock price of Isosceles Pharmaceuticals?
Isosceles Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Isosceles Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Isosceles Pharmaceuticals worth (valuation)?
Valuation information for Isosceles Pharmaceuticals is not publicly available.
Can I buy Isosceles Pharmaceuticals stock?
Isosceles Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Isosceles Pharmaceuticals's last funding round?
Isosceles Pharmaceuticals's most recent funding round was Seed on May 1, 2023.
Who are the main investors in Isosceles Pharmaceuticals?
Key investors in Isosceles Pharmaceuticals include North Carolina Biotechnology Center.
Will Isosceles Pharmaceuticals IPO soon?
No public IPO plans have been announced for Isosceles Pharmaceuticals.
How can I track Isosceles Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Isosceles Pharmaceuticals's shares on secondary markets.